Kong, Jianqiu
Zheng, Junjiong
Cai, Jinhua
Wu, Shaoxu
Diao, Xiayao
Xie, Weibin
Chen, Xiong
Liao, Chenyi
Yu, Hao
Fan, Xinxiang
Huang, Chaowen
Liu, Zhuowei
Chen, Wei
Lv, Qiang
Qin, Haide
Huang, Jian
Lin, Tianxin
Funding for this research was provided by:
Natural Science Foundation of China (81572514, U1301221, 81402106, 81272808, 81825016)
Natural Science Foundation of Guangdong, China (2016A030313244)
Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology ([2013]163)
Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes (KLB09001)
Guangdong Science and Technology Department (2015B050501004, 2017B020227007)
Article History
Received: 27 June 2019
Accepted: 14 November 2019
First Online: 27 November 2019
Ethics approval and consent to participate
: For the Chinese multicenter dataset, the retrospective analysis of anonymous patient data was approved by the institutional review board at each participating institution.
: Not applicable.
: The authors declare that they have no competing interests.